Global High Pressure Contrast Media Injectors Market by Product (Injector Systems, Consumables), by End-use (Hospitals, Diagnostic Centers) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global high pressure contrast media injections market was valued at USD 119.5 million in 2020. It is expected to grow at 12.1% compound annual growth rate (CAGR), between 2021 and 2028. In the next few years, the increasing prevalence of chronic conditions like cancer, neurovascular disease, and cardiovascular disease will likely increase the demand for high-pressure contrast media injectors. The WHO estimates that cancer was responsible for almost 10 million deaths in 2020. The high pressure contrast media injectors are now automated, whereas the manual injectors used to have stop-cocks. These systems offer greater precision and benefits.

The market is driven by the integration of modern technology with traditional high-pressure contrast media injectors. IT-enabled solutions are available for high pressure automated and syringeless injectors. Syringeless power injectors, which reduce contrast media waste, have gained widespread acceptance in recent years. Syringeless injectors are also known to reduce exam time, which results in higher patient turnover. The market is limited by the high price of high pressure contrast media injectors and consumables as well as accessories.

Market growth is expected to be affected by the recent COVID-19 pandemic. Lockdown and social distancing have limited outpatient services at dispensaries, clinics, nursing homes, and smaller hospitals. This has resulted in fewer referrals to imaging tests. Patients have been restricted in their movement. Due to financial stress, patients are putting off non-urgent procedures. The market may see a slight decline in revenue and imaging volumes as outpatient elective imaging procedures are not covered. In the long run, however, digital health services such as telemedicine/teleradiology, artificial intelligence, and deep learning technologies are expected to accelerate and gain widespread acceptance.

Artificial intelligence is gaining popularity in the healthcare industry. High pressure contrast media injector manufacturers are working to develop intelligent devices that minimize human error. Interface systems like Radiology Information System (RIS) and Picture Archive and Communication System are helpful in collecting patient information and administering appropriate amounts of contrast. Bracco Group Company developed high-pressure contrast media injectors to be used in intravenous procedures such as CT and MRI.

Product Insights

Consumables dominated the market, accounting for the largest revenue share at 61.3% in 2020. This segment is forecast to grow at 11.7% over the forecast period. This segment's rapid growth can be attributed to factors like high disposable device usage, safety features, user-friendliness, efficiency, and lower contrast media wastage. Further, the consumable segment can be divided into tubings and syringes. This consumable segment must be repurchased for each new procedure, as opposed to instruments. In 2020, the market share for other consumables was the highest while the syringes segment is expected to grow the fastest. Many major manufacturers have been focusing their efforts on developing and introducing syringeless injections to increase the segment's growth.

This is due to the growing product demand and the fact that the injector systems can be used on multiple patients. The segment of injector systems will see the fastest growth over the forecast period. This results in less waste, shorter contrast preparation times, lower disposable costs, and greater radiographer satisfaction.

Type Insights

In 2020, the single head segment was the dominant market segment and earned 44.6% of the total revenue. MRI, CT, and angiography are the most popular applications. The low cost of these devices is expected to drive demand in emerging countries like Brazil, India, China, and China. The emergence of new products is expected to also help this segment grow.

Over the forecast period, the dual head injector market segment will see a significant CAGR. These injectors offer the advantage of faster operation and controlled delivery. Modern contrast injection systems incorporate enhancements that improve patient safety and workflow efficiency, as well as injector protocol data management.

Application Insights

Interventional cardiology dominated the high pressure contrast media injectors market and held the largest revenue share at 35.5% in 2020. This segment is forecast to grow at 11.8% over the forecast period. The demand for cardiac interventional surgery has increased due to the rising prevalence of cardiovascular issues. Market growth is expected to be driven by increased demand for innovative products that are precise and efficient over the forecast period. The World Health Organization estimates that 17.9 million people died in 2019 from cardiovascular disease. This account accounts for 32% of all global deaths. By 2030, cardiovascular disease will claim 23.6 million lives.

As interventional radiology is used to diagnose many disorders including cancer, heart disease, broken bones and blood clots, it is expected to grow at the fastest pace during the forecast period. The segment's growth has also been helped by an increase in the demand for non-invasive medical image procedures and technical advances.

End-use Insights

In 2020, the hospitals segment was the dominant market player and had a 60.8% revenue share. This segment is expected to grow the fastest during the forecast period due to the increase in hospitalizations of patients with neurological and cancer conditions. Because of the wide range of applications of high-pressure contrast media injectors in radiology and interventional radiology as well as interventional cardiology, hospitals are the main users. This segment's growth can also be linked to the increasing number of diagnostic imaging procedures performed at hospitals, rising use of minimally invasive procedures (including imaging systems) in hospitals to improve care quality, as well as hospitals' preference for automation and digitization in radiology patient workflow. The segment's growth will be supported by an increasing focus on developing healthcare facilities in emerging regions in Africa and Asia Pacific.

The segment of diagnostic centers is expected to see significant growth over the forecast period. This segment is driven by a greater understanding of neurodegenerative diseases and chronic diseases like cancer. The increasing awareness of chronic diseases is driving a rise in demand for CT/MRI treatments. These are used to diagnose, plan treatment, and prevent them from developing. These centers offer a wide range of preventative and diagnostic services. These centers are a great option because most hospitals don't have the space needed to house specialized imaging equipment rooms. These facilities also provide services to many hospitals. These facilities have more frequent upgrades to their imaging equipment than hospitals.

Regional Insights

North America was the dominant market for high pressure contrast media injectors in 2020, accounting for 39.1% of the total revenue. Over the forecast period, the region will see a CAGR greater than 11.0%. North America's market is driven by factors such as the rapid adoption of new technologies, a strong healthcare infrastructure, and fair reimbursement. The demand for high-pressure contrast media injectors will rise due to an increase in cancer rates, neurology diseases and cardiovascular disease, as well as increased accident and trauma cases that require contrast studies. Europe was second in revenue, just behind North America.

Asia Pacific is expected to experience the fastest growth in the market over the forecast period. This is due to increasing healthcare spending and rapidly evolving healthcare infrastructure. The market is also expected to grow due to the increasing prevalence of chronic diseases like epilepsy, cancer, and orthopedic ailments.

Market Share Insights & Key Companies

The market is extremely competitive. Market players have taken key strategic initiatives such as new product development, mergers and acquisitions, partnerships, collaborations, and partnership building. Bayer Radiology, for instance, announced Radimetrics 3.0 in December 2020. Radimetrics 3.0 offers enhanced functionality and features that help to manage radiation dose and contrast dose throughout all stages of the care chain. The market leader in high pressure contrast media injectors is:

• Bracco Group

• Guerbet Group

• Medtron AG

• Bayer HealthCare LLC

• ulrich GmbH & Co. KG

• NemotoKyorindo Co., Ltd.

• GE Healthcare

• Sino Medical-Device Technology Co.

• Apollo RT Co. Ltd.

• VIVID IMAGING

Up Market Research published a new report titled “High Pressure Contrast Media Injectors Market research report which is segmented by Product (Injector Systems, Consumables), by End-use (Hospitals, Diagnostic Centers), By Players/Companies Guerbet Group, Medtron AG, VIVID IMAGING, ulrich GmbH & Co KG, Bayer HealthCare LLC, Bracco Group, Sino Medical-Device Technology Co, NemotoKyorindo Co Ltd, Apollo RT Co Ltd, GE Healthcare”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global High Pressure Contrast Media Injectors Market Report Segments:

The market is segmented by Product (Injector Systems, Consumables), by End-use (Hospitals, Diagnostic Centers).

High Pressure Contrast Media Injectors Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the High Pressure Contrast Media Injectors Market

Overview of the regional outlook of the High Pressure Contrast Media Injectors Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The High Pressure Contrast Media Injectors Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of High Pressure Contrast Media Injectors Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Injector Systems

                2. Consumables

                1. Hospitals

                2. Diagnostic Centers

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the High Pressure Contrast Media Injectors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the High Pressure Contrast Media Injectors Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.